1. 295 NUCLEOLIN, A NOVEL TARGET FOR APTAMER-BASED ANTICANCER THERAPY. (1st January 2005) Authors: Miller, D. M.; Bates, P.; Trent, J.; Sharma, V.; Thomas, S.; Barnhart, K.; Laber, D. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1642: OUTCOMES IN HOSPITALIZED PATIENTS WITH COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY. (23rd June 2022) Authors: Logothetis, C.; Finley, K.; Huang, S.; Wood, A.; Laber, D.; Eatrides, J. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient. Issue 4 (12th April 2017) Authors: Sam, C.; Desai, P.; Laber, D.; Patel, A.; Visweshwar, N.; Jaglal, M. Journal: Transfusion medicine Issue: Volume 27:Issue 4(2017:Aug.) Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗